<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>Emergent BioSolutions RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><image><url>http://images.finanzen.net/images/finanzen_net_neu.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>Emergent BioSolutions: Abbott beendet Entwicklungsabkommen</title><link>http://www.finanzen.net/nachricht/aktien/Emergent-BioSolutions-Abbott-beendet-Entwicklungsabkommen-1535602</link><description>Abott Park (aktiencheck.de AG) - Der US-Pharmakonzern &lt;a href="/aktien/Abbott_Laboratories-Aktie"&gt;Abbott Laboratories&lt;/a&gt;  hat ein Entwicklungsabkommen mit dem US-Impfstoffhersteller &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt;  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Emergent-BioSolutions-Abbott-beendet-Entwicklungsabkommen-1535602</guid></item><item><title>Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-Chairman-and-CEO-Fuad-El-Hibri-Recognized-as-Outstanding-International-Business-Leader-756248</link><description>
			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE:EBS) announced today that Fuad 
      El-Hibri, its chairman and chief executive officer, has been named by 
      the World Trade Center Institute (WTCI)  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-Chairman-and-CEO-Fuad-El-Hibri-Recognized-as-Outstanding-International-Business-Leader-756248</guid></item><item><title>Emergent BioSolutions Reports Financial Results for Full Year 2009</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-Reports-Financial-Results-for-Full-Year-2009-752570</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwcellpaddingbottom1 {padding-bottom: 2.0px}
.bwcellpaddingleft0 {padding-left: 0.0px}
.bwcellpaddingleft3 {padding-left: 15.0px}
.bwcellpaddingleft5 {padding-left: 25.0px}
.bwcellpaddingright0 {padding-right: 0.0px}
.bwcellparagraphmargin  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-Reports-Financial-Results-for-Full-Year-2009-752570</guid></item><item><title>Emergent BioSolutions to Participate in March 2010 Investor Conferences</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-to-Participate-in-March-2010-Investor-Conferences-745876</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmarginbottom {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE: EBS) announced today that the company 
      will be participating  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-to-Participate-in-March-2010-Investor-Conferences-745876</guid></item><item><title>Emergent BioSolutions to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March 4, 2010</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-to-Release-Fourth-Quarter-and-Full-Year-2009-Financial-Results-and-Conduct-a-Conference-Call-on-March-4-2010-731618</link><description>
			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE: EBS) announced today it will report 
      financial results for fourth quarter and full year 2009 on Thursday, 
      March 4, 2010, after market close.
  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-to-Release-Fourth-Quarter-and-Full-Year-2009-Financial-Results-and-Conduct-a-Conference-Call-on-March-4-2010-731618</guid></item><item><title>Emergent BioSolutions Announces R. Don Elsey, Chief Financial Officer, to Join Board of Directors of MdBio Foundation</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-Announces-R-Don-Elsey-Chief-Financial-Officer-to-Join-Board-of-Directors-of-MdBio-Foundation-725040</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwtextaligncenter {text-align: center}
--&gt;
&lt;/style&gt;

			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE:EBS) announced today that R. Don Elsey, 
      chief financial officer  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-Announces-R-Don-Elsey-Chief-Financial-Officer-to-Join-Board-of-Directors-of-MdBio-Foundation-725040</guid></item><item><title>Emergent BioSolutions Provides Preliminary 2009 Financial Results and Guidance for 2010</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-Provides-Preliminary-2009-Financial-Results-and-Guidance-for-2010-724978</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmarginbottom {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE:EBS) announced today preliminary, 
      unaudited financial results  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-Provides-Preliminary-2009-Financial-Results-and-Guidance-for-2010-724978</guid></item><item><title>HHS Cancels RFP for rPA Procurement and Modifies Their Approach in Favor of BAA for Development of rPA Vaccines</title><link>http://www.finanzen.net/nachricht/HHS-Cancels-RFP-for-rPA-Procurement-and-Modifies-Their-Approach-in-Favor-of-BAA-for-Development-of-rPA-Vaccines-712616</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmarginbottom {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE:EBS) announced today that it has been 
      advised by the Office  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/HHS-Cancels-RFP-for-rPA-Procurement-and-Modifies-Their-Approach-in-Favor-of-BAA-for-Development-of-rPA-Vaccines-712616</guid></item><item><title>Former U.K. Health Protection Agency Director Rejoins Emergent BioSolutions to Head Biodefense Business</title><link>http://www.finanzen.net/nachricht/Former-U-K-Health-Protection-Agency-Director-Rejoins-Emergent-BioSolutions-to-Head-Biodefense-Business-709531</link><description>
			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE:EBS) is pleased to announce the 
      appointment of Steven Chatfield, Ph.D. as Senior Vice President, 
      Biodefense effective immediately. Dr. Chatfield  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Former-U-K-Health-Protection-Agency-Director-Rejoins-Emergent-BioSolutions-to-Head-Biodefense-Business-709531</guid></item><item><title>Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences</title><link>http://www.finanzen.net/nachricht/Emergent-BioSolutions-to-Webcast-Presentations-at-Upcoming-Investor-Conferences-708990</link><description>
&lt;style type="text/css"&gt;
&lt;!-- 
.bwlistitemmarginbottom {margin-bottom: 10.0px}
--&gt;
&lt;/style&gt;

			
      &lt;a href="/aktien/Emergent_BioSolutions-Aktie"&gt;Emergent BioSolutions&lt;/a&gt; Inc. (NYSE: EBS) announced today that the company 
      will be webcasting  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/Emergent-BioSolutions-to-Webcast-Presentations-at-Upcoming-Investor-Conferences-708990</guid></item></channel></rss>

